Author: Sydney E. SalmonPublisher:
ISBN:
Category :
Languages : en
Pages : 629
Book Description
Adjuvant Therapy of Cancer, VI
Adjuvant Therapy of Primary Breast Cancer VI
Author: Hans-Jörg SennPublisher: Springer Science & Business Media
ISBN: 364245769X
Category : Medical
Languages : en
Pages : 505
Book Description
This RRCR-conference-volume marks "number six" in a 20-year evolution of international conferences on the adjuvant therapy of primary breast cancer. Starting in 1978, a handful of some 80 en thusiastic breast cancer surgeons and oncologists, met in a se cluded mountain resort near st. Gallen in Eastern Switzerland, to exchange their early data of some pioneer trials on adjuvant sys temic therapy of early breast cancer, and to correlate their future research efforts to overcome the frustrating prognostic stagna tion of this dominant neoplastic disease in Western females dur ing the past decades. Repeated every 3-4 years, these St. Gallen International Conferences on Adjuvant Therapy of Primary Breast Cancer have continuously grown in numbers of partici pants and in normative, therapeutic influence by being published in major oncology journals [1-3], the last (6th) conference hav ing taken place from February 25-28, 1998 with more than 1800 attendees from over 50 countries worldwide. What is the fascination of adjuvant therapy in primary (early) breast cancer, and what has changed,during the last 3 years since March 1995, to justify another international gathering of this size, and of the world's leading experts in the field? There is no question, that providing even more effective care and designing appropriate recommendations for the multitudes of patients with so-called early breast cancer or at high risk of developing the disease, remain highly important public health goals.
Adjuvant Therapy for Breast Cancer
Author: Monica CastiglionePublisher: Springer Science & Business Media
ISBN: 0387751157
Category : Medical
Languages : en
Pages : 483
Book Description
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.
Adjuvant Therapy of Cancer VI
Author: Sydney E. SalmonPublisher:
ISBN:
Category : Cancer
Languages : en
Pages : 0
Book Description
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II
Author: Gianni BonadonnaPublisher: Springer Science & Business Media
ISBN: 3642813321
Category : Medical
Languages : en
Pages : 479
Book Description
1978 Annual Plenary Meeting of the European Organization for Research on Treatment of Cancer, Paris, June 1978
Adjuvant Chemotherapy of Breast Cancer
Author: Hans-Jörg SennPublisher: Springer Science & Business Media
ISBN: 3642823572
Category : Medical
Languages : en
Pages : 302
Book Description
H.-J. Senn Adjuvant Chemotherapy (ACT) of breast cancer has now emerged as one of the controversial su):>jects in clinical and also experimental oncology. Driven by growing frustration about stagnating cure rates in breast cancer [1,4] and stimulated by elegant demonstration of highly curative effects of adjuvant systemic therapy in animal models [6, 11] and in several childhood neoplasias [15], researchers introduced ACT to the primary treatment of breast cancer with great hope some 15 years ago. After a first wave of isolated "historic" trials with generally limited but in one case remarkable success [5, 9], a second generation of ACT studies was initiated by NSABP investigators and oncology centers in Europe [2, 6, 13]. These trials were well conducted statistically and diagnostically, and all in the early 1970s included a surgical control arm. Early and intermediate beneficial effects on relapse-free survival (RFS) after 2-3 years median observation time then prompted a whole series of ACT studies in breast cancer. These "third-gener ation" studies usually regarded some positive influence of ACT as a given fact, dropping surgical control regimens and comparing different ACT regimens, hopefully in a prospective, randomized way 1984 Fig. 1. The mushrooming of adjuvant studies in breast cancer XII Introduction [reviews in 3, 14]. The "mushrooming" of ACT studies in breast cancer during the last 10 and especially 5 years is demonstrated in Fig. 1, and it gets really cumbersome even for the insider to keep on top of the multitude of sometimes conflicting data.
Adjuvant Therapy of Cancer VIII
Author: Sydney E. SalmonPublisher: Lippincott Williams & Wilkins
ISBN: 9780397584437
Category : Medical
Languages : en
Pages : 330
Book Description
Lung Cancer Therapy Annual 6
Author: Heine H. HansenPublisher: CRC Press
ISBN: 0203092139
Category : Medical
Languages : en
Pages : 238
Book Description
Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of Lung Cancer Therapy Annual briefs the oncology community with a review of the recent literature, emphasizing the therapeutic aspects. It offers an update of the impact that this information will have on the day-to-day management of the lung cancer pat
Treatment of Soft Tissue Sarcomas
Author: H.M. PinedoPublisher: Springer Science & Business Media
ISBN: 1461317576
Category : Medical
Languages : en
Pages : 143
Book Description
One of the major advances of the last decade concerning the treatment of patients with soft tissue sarcomas is that an increased number of patients are being discussed in multidisciplinary teams prior to the initial treatment. The present volume on soft tissue sarcomas in the series Cancer Treatment and Research reflects the multidisciplinary approach with a focus on recent developments. The availability of new histopathologic techniques has reduced the number of unclassified sarcomas and has furhter increased the importance of the histo pathologist in providing estimates of the prognosis of the patient as well as data for the planning of treatment strategy. Further data for this strategy will be provided by diagnostic imaging. In this field, the role of magnetic reson ance imaging has been further defined. Of utmost importance is the recent trend toward consensus in staging. The modification of the staging system of the American Joint Commission for Cancer Staging and End Results Report ing brings the possibility of a single staging system within reach in the next decade. As surgery still provides the only chance for cure, the importance of being the most sparing as possible is obvious. For this reason, radiotherapy has been applied with success. The introduction of relatively new radiation tech niques is therefore being observed with interest.
Author: